Industry News


Bioness to Market L300 Foot Drop System to Pediatric Patients, Caregivers

L300 regular_and_smallBioness Inc, Valencia, Calif, has received 510(K) clearance from the FDA to market its L300 Foot Drop System to pediatric patients and their caregivers. The L300 is a neuromodulation technology designed to treat foot drop and is the first neuromuscular stimulation device cleared by the FDA. The device is worn on the leg, and by lifting the foot at the appropriate time, a patient may be able to walk with increased confidence, reduced fatigue, and improved speed. In addition to aiding children with mobility issues, Bioness reports that the pediatric L300 can also be used for gait rehabilitation in inpatient or outpatient rehabilitation settings.

For additional information about this device, visit www.bioness.com.

[Source: Bioness]